Get the weekly research letter
Companies change their terms quietly. We read every version and catch what actually changed. One email a week on the changes that matter and what they mean. No account.
The policy restricts or prohibits pharmacies, prescription drug sales, drug paraphernalia, and products that mimic illegal drug effects from accessing Stripe's payment processing, with licensed pharmacies potentially eligible for restricted status subject to prior written approval.
This analysis describes what Stripe's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision requires pharmaceutical merchants and supplement sellers to evaluate whether their products fall within the restricted or prohibited category before onboarding, particularly given the broad framing of substances that mimic illegal drug effects, which may affect certain nutraceutical and hemp-derived product sellers.
Interpretive note: The scope of substances that mimic illegal drug effects is not precisely defined in the document, creating interpretive uncertainty for businesses selling legal psychoactive or nootropic products whose classification under this provision may depend on Stripe's internal determination.
Under this provision, pharmacies and businesses selling prescription drugs must obtain prior written approval from Stripe before processing payments, while sellers of drug paraphernalia and substances mimicking illegal drugs are prohibited entirely. Merchants in adjacent categories such as hemp-derived products or supplements should evaluate their product classification under this policy.
How other platforms handle this
Discriminate regarding access to communities or groups that you create, manage, lead, or participate in.
Please take steps to secure your access credentials such as login name and password, and do not share them with anyone.
if you do choose to upload your photograph to our Service, please note that all images must adhere to our App Use Standards which you are required to comply with to use any of the Robinhood Services.
Monitoring
Stripe has changed this document before.
Receive same-day alerts, structured change summaries, and monitoring for up to 20 platforms.
"Pharmacies and the sale of prescription drugs, as well as the sale of substances that mimic the effects of illegal drugs, sale of drug paraphernalia, and related items are among the categories restricted or prohibited from using Stripe's services.Excerpt from Stripe's Restricted Businesses List
(1) REGULATORY LANDSCAPE: Prescription drug sales engage FDA regulations, the Drug Enforcement Administration's controlled substances scheduling, and state pharmacy board licensing requirements. Online pharmacy operations interact with the Ryan Haight Online Pharmacy Consumer Protection Act in the US. Hemp and CBD products occupy a regulatory grey area under the 2018 Farm Bill and FDA enforcement discretion policies. (2) GOVERNANCE EXPOSURE: Medium. The provision's reference to substances that mimic illegal drug effects creates interpretive uncertainty for businesses selling legal but psychoactive products including certain herbal supplements, kratom, and hemp-derived products, as Stripe's classification of these products may not align with the seller's own legal analysis. (3) JURISDICTION FLAGS: State pharmacy licensing requirements vary and create a multi-jurisdictional compliance matrix for online pharmacy operators. International pharmaceutical sales engage additional import/export restrictions and regulatory frameworks that interact with this provision. (4) CONTRACT AND VENDOR IMPLICATIONS: Marketplaces and e-commerce platforms hosting pharmaceutical or supplement merchants should include product category screening in vendor onboarding. Businesses should not assume that a product's legal status under applicable law determines its classification under Stripe's policy. (5) COMPLIANCE CONSIDERATIONS: Pharmaceutical merchants should document their licensing status and product regulatory classification before seeking Stripe approval. Businesses selling hemp or CBD products should contact Stripe to confirm category classification given the evolving regulatory environment.
Regulatory citations, enforcement risk, and due diligence action items.
Provision-level monitoring, governance timelines, and regulatory mapping built from archived source documents and historical version tracking.
This provision requires pharmaceutical merchants and supplement sellers to evaluate whether their products fall within the restricted or prohibited category before onboarding, particularly given the broad framing of substances that mimic illegal drug effects, which may affect certain nutraceutical and hemp-derived product sellers.
Under this provision, pharmacies and businesses selling prescription drugs must obtain prior written approval from Stripe before processing payments, while sellers of drug paraphernalia and substances mimicking illegal drugs are prohibited entirely. Merchants in adjacent categories such as hemp-derived products or supplements should evaluate their product classification under this policy.
ConductAtlas has identified this type of provision across 287 platforms. See the full comparison.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by Stripe.